Baird Medical Advances Thyroid MWA Training and Academic Exchange with Leading Harvard Professor

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a leader in Microwave Ablation (MWA) technology, recently hosted an advanced training session and academic exchange in New Orleans, reinforcing its commitment to clinical innovation and research collaboration in minimally invasive thyroid therapies.

The program was led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, a leading figure in thyroid ablation and endocrine surgery. He was joined by Dr. Gregory Randolph, Professor of Otolaryngology–Head and Neck Surgery at Harvard Medical School and the Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology. Visiting Tulane as a Distinguished Professor on May 9, 2025, Dr. Randolph engaged in academic discussions with Dr. Kandil on a range of thyroid-focused topics.

Following their exchange, Dr. Randolph participated in clinical observations and hands-on procedures alongside Dr. Kandil. The two experts also explored emerging technologies and discussed opportunities for future research collaboration in the field of thyroid surgery.

This initiative is part of Baird Medical’s broader strategy to promote excellence in thyroid care by partnering with world-class medical leaders. Through advanced training and academic partnerships, the Company continues to support the global adoption of innovative, minimally invasive therapies.